Immunotherapy for advanced or metastatic urothelial carcinoma: an abridged Cochrane review.
To assess the effects of immunotherapy compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.
Based on a published protocol, we performed a systematic search of multiple databases.